MARADMINS : 418/18
R 261415Z JUL 18
MSGID/GENADMIN/CMC WASHINGTON DC DMCS//
SUBJ/2018-19 SEASONAL INFLUENZA VACCINE GUIDANCE FOR ACTIVE AND RESERVE COMPONENTS//
REF/A/DOC/BUMED WASHINGTON DC/20131007//
REF/B/MSG/CMC WASHINGTON DC PP0/20101105//
REF/C/DOC/CNO WASHINGTON DC/20161122//
REF/D/DOC/32 CFR PART 199.21/20161201//
NARR/REF A IS BUMEDINST 6230.15B, IMMUNIZATIONS AND
CHEMOPROPHYLAXIS. REF B IS MARADMIN 631/10, REQUIREMENT TO TRACK
AND IMPROVE INDIVIDUAL MEDICAL READINESS FOR ACTIVE AND RESERVE
COMPONENTS. REF C IS OPNAVINST 3710.7V, NAVAL AIR TRAINING AND
OPERATING PROCEDURES STANDARDIZATION GENERAL FLIGHT AND OPERATING
INSTRUCTIONS. REF D IS THE CIVILIAN HEALTH AND MEDICAL PROGRAM OF
THE UNIFORMED SERVICES (CHAMPUS)/TRICARE: TRICARE PHARMACY
POC/BROOM, KIMBERLY/CDR/HQMC/HS/TEL: 703-604-4602/EMAIL: KIMBERLY.BROOM@USMC.MIL, DIRECTOR OF PUBLIC HEALTH//
POC/ANCHETA, ERIC/HMC/HQMC/PPO/TEL: 703-571-1041/EMAIL: ERIC.ANCHETA@USMC.MIL, MRRS COORDINATOR//
GENTEXT/REMARKS/1. Purpose. Provide guidance to Marine Corps active and reserve components to implement the 2018-2019 mandatory Seasonal Influenza Vaccination Program. The Department of Defense goal is 90 percent of personnel vaccinated no later than Saturday, 15 December 2018.
2. Background. Seasonal influenza is a highly contagious disease that has the potential to severely reduce mission readiness. A timely comprehensive vaccination program must be enforced by leadership throughout the Marine Corps to mitigate mission risk. Maximum and early influenza vaccination compliance reduces severity of the disease in Marines who become exposed to the virus and strengthens the ability of the force to limit spread of the disease.
a. Per refs (a) and (b), Marine Corps active and reserve component personnel shall receive the seasonal influenza vaccine annually, unless medically exempt.
b. Marine Corps active and reserve component commands shall monitor influenza vaccination compliance closely in the Medical Readiness Reporting System (MRRS) and coordinate with supporting medical commands to ensure a 90 percent seasonal influenza vaccination compliance rate is achieved no later than 15 December 2018.
c. Per ref (b), MRRS will be used to enter vaccination status and monitor compliance. Delinquent personnel will be identified by the command and directed to receive the vaccine at the earliest opportunity.
d. Exemptions will be entered in MRRS only when an individual has a valid exemption for the influenza vaccine.
e. Notify Headquarters Marine Corps (HQMC) Health Services point of contact (POC) via the chain of command if 90 percent compliance is not expected to be achieved by 15 December 2018 to coordinate mitigation strategies with supporting organizations. Based on previous experiences, major commands should attain at least 75 percent compliance in their roll-up reports by 1 November 2018 to be on track to achieve the 90 percent compliance by 15 December 2018.
4. Vaccine administration. The Centers for Disease Control vaccine information sheets will be reviewed by each Marine prior to vaccination. The injectable vaccine will be available for the 2018-19 influenza season. The intranasal FluMist will not be provided through the central ordering process, but will be available by special request. The inactivated vaccine (injectable) requires a 12-hour grounding period for all personnel in an active flying status.
5. Adverse reactions. In the event of an adverse reaction, members should report to medical and a vaccine adverse event report should be submitted. Instructions can be found at the vaers.hhs.gov website which is also referenced within the MRRS immunization reaction section.
a. Vaccinations will be documented in the members health record and recorded in MRRS within 24 hours of administration.
b. Ref (d) allows Tricare Prime enrolled members, which includes all active duty service members, to use Tricare authorized pharmacies to receive the seasonal influenza vaccine as part of their pharmacy benefit. There should be no cost for active duty personnel or other Tricare Prime beneficiaries. Personnel using this option must provide their MRRS representative and medical facility documentation of the manufacturer, lot number, amount and location given (right arm, left arm), and date of administration of the vaccine within one business day for inclusion in MRRS and their medical record. Commands must ensure that documentation of influenza vaccine administration is coded to accurately reflect the type of vaccine given.
c. MRRS provides drill down capability to track compliance from the major subordinate command level to the individual Marine level. If a command does not have access to MRRS, contact the local MRRS security officer or the HQMC Plans, Policy, and Operations POC listed in this message for further assistance.
7. This MARADMIN is applicable to the total force Marine Corps.
8. This MARADMIN is cancelled 1 August 2019.
9. Release authorized by Lieutenant General Michael G. Dana, Director, Marine Corps Staff.//